• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激酶在慢性髓性白血病人类细胞模型中端粒复合物的差异调控:从单细胞分析到下一代测序。

Differential Regulation of Telomeric Complex by Kinase in Human Cellular Models of Chronic Myeloid Leukemia-From Single Cell Analysis to Next-Generation Sequencing.

机构信息

Department of Biotechnology, University of Rzeszow, Pigonia 1, 35-310 Rzeszów, Poland.

Postgraduate School of Molecular Medicine, Medical University of Warsaw, Trojdena 2a, 02-091 Warsaw, Poland.

出版信息

Genes (Basel). 2020 Sep 29;11(10):1145. doi: 10.3390/genes11101145.

DOI:10.3390/genes11101145
PMID:33003326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7601685/
Abstract

Telomeres are specialized nucleoprotein complexes, localized at the physical ends of chromosomes, that contribute to the maintenance of genome stability. One of the features of chronic myeloid leukemia (CML) cells is a reduction in telomere length which may result in increased genomic instability and progression of the disease. Aberrant telomere maintenance in CML is not fully understood and other mechanisms such as the alternative lengthening of telomeres (ALT) are involved. In this work, we employed five -positive cell lines, namely K562, KU-812, LAMA-84, MEG-A2, and MOLM-1, commonly used in the laboratories to study the link between mutation, copy number, and expression of telomere maintenance genes with the expression, copy number, and activity of . Our results demonstrated that the copy number and expression of are crucial for telomere lengthening. We observed a correlation between expression and telomere length as well as shelterins upregulation. Next-generation sequencing revealed pathogenic variants and copy number alterations in major tumor suppressors, such as TP53 and CDKN2A, but not in telomere-associated genes. Taken together, we showed that kinase expression and activity play a crucial role in the maintenance of telomeres in CML cell lines. Our results may help to validate and properly interpret results obtained by many laboratories employing these in vitro models of CML.

摘要

端粒是位于染色体物理末端的特殊核蛋白复合物,有助于维持基因组稳定性。慢性髓系白血病 (CML) 细胞的一个特征是端粒长度缩短,这可能导致基因组不稳定性增加和疾病进展。CML 中端粒维持的异常机制尚不完全清楚,其他机制,如端粒的替代性延长 (ALT) 也参与其中。在这项工作中,我们使用了五个阳性细胞系,即 K562、KU-812、LAMA-84、MEG-A2 和 MOLM-1,这些细胞系常用于实验室研究端粒维持基因的突变、拷贝数和表达与 的表达、拷贝数和活性之间的联系。我们的结果表明, 的拷贝数和表达对于端粒延长至关重要。我们观察到 表达与端粒长度以及庇护素上调之间存在相关性。下一代测序揭示了主要肿瘤抑制基因,如 TP53 和 CDKN2A 的致病性变异和拷贝数改变,但在端粒相关基因中没有发现。总之,我们表明 激酶的表达和活性在 CML 细胞系中端粒的维持中起着至关重要的作用。我们的结果可能有助于验证和正确解释许多实验室使用这些 CML 体外模型获得的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/63cd43b94928/genes-11-01145-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/5a257c391a48/genes-11-01145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/7b9683908776/genes-11-01145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/c11802a0cbea/genes-11-01145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/44b1f3c83c1b/genes-11-01145-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/63cd43b94928/genes-11-01145-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/5a257c391a48/genes-11-01145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/7b9683908776/genes-11-01145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/c11802a0cbea/genes-11-01145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/44b1f3c83c1b/genes-11-01145-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f786/7601685/63cd43b94928/genes-11-01145-g005.jpg

相似文献

1
Differential Regulation of Telomeric Complex by Kinase in Human Cellular Models of Chronic Myeloid Leukemia-From Single Cell Analysis to Next-Generation Sequencing.激酶在慢性髓性白血病人类细胞模型中端粒复合物的差异调控:从单细胞分析到下一代测序。
Genes (Basel). 2020 Sep 29;11(10):1145. doi: 10.3390/genes11101145.
2
The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.端粒复合物成员与 BCR::ABL1 致癌酪氨酸激酶在慢性髓细胞白血病中端粒长度维持中的相互作用。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7103-7112. doi: 10.1007/s00432-023-04662-w. Epub 2023 Mar 5.
3
miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.miR-96 通过靶向慢性髓系白血病原始细胞转化中的 BCR-ABL1 癌基因发挥肿瘤抑制作用。
Biomed Pharmacother. 2019 Nov;119:109413. doi: 10.1016/j.biopha.2019.109413. Epub 2019 Sep 10.
4
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.BCR-ABL1 通过 MYC 介导的 miR-150 下调导致慢性髓性白血病中的骨髓分化阻滞和耐药。
Haematologica. 2018 Dec;103(12):2016-2025. doi: 10.3324/haematol.2018.193086. Epub 2018 Jul 26.
5
Molecular biology of bcr-abl1-positive chronic myeloid leukemia.bcr-abl1 阳性慢性髓性白血病的分子生物学
Blood. 2009 Feb 19;113(8):1619-30. doi: 10.1182/blood-2008-03-144790. Epub 2008 Sep 30.
6
RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.RAG通过其核酸内切酶活性在体外和体内增强BCR-ABL1阳性白血病细胞的生长。
Cancer Sci. 2021 Jul;112(7):2679-2691. doi: 10.1111/cas.14939. Epub 2021 May 18.
7
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants.在接受二线酪氨酸激酶抑制剂治疗的慢性髓性白血病患者中,在出现警示时对BCR-ABL1进行深度测序可能有助于灵敏检测新出现的耐药突变体。
BMC Cancer. 2016 Aug 2;16:572. doi: 10.1186/s12885-016-2635-0.
8
Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia.miR-30a 水平降低与慢性髓性白血病中 ABL1 和 BCR-ABL1 表达增强相关。
Leuk Res. 2013 Mar;37(3):349-56. doi: 10.1016/j.leukres.2012.12.003. Epub 2013 Jan 1.
9
Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia.Fyn 的表达和活性介导慢性髓性白血病的增殖和原始细胞特征。
PLoS One. 2012;7(12):e51611. doi: 10.1371/journal.pone.0051611. Epub 2012 Dec 17.
10
Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia.荧光原位杂交鉴定的异质性 BCR-ABL1 信号模式与 BCR-ABL1 阳性白血病中的白血病克隆进化和预后不良相关。
BMC Cancer. 2019 Oct 8;19(1):935. doi: 10.1186/s12885-019-6137-8.

引用本文的文献

1
Changes in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation.白细胞和白血病细胞经超短电子束辐射后端粒长度的变化。
Int J Mol Sci. 2024 Jun 18;25(12):6709. doi: 10.3390/ijms25126709.
2
The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.端粒复合物成员与 BCR::ABL1 致癌酪氨酸激酶在慢性髓细胞白血病中端粒长度维持中的相互作用。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7103-7112. doi: 10.1007/s00432-023-04662-w. Epub 2023 Mar 5.
3
Highly precise breakpoint detection of chromosome balanced translocation in chronic myelogenous leukaemia: Case series.

本文引用的文献

1
Role of Rap1 in DNA damage response: implications in stem cell homeostasis and cancer.Rap1 在 DNA 损伤反应中的作用:对干细胞动态平衡和癌症的影响。
Exp Hematol. 2020 Oct;90:12-17. doi: 10.1016/j.exphem.2020.08.009. Epub 2020 Aug 26.
2
JAK2 inhibition in JAK2-bearing leukemia cells enriches CD34 leukemic stem cells that are abolished by the telomerase inhibitor GRN163L.JAK2 抑制在携带 JAK2 的白血病细胞中富集 CD34 白血病干细胞,而端粒酶抑制剂 GRN163L 则可消除这些细胞。
Biochem Biophys Res Commun. 2020 Jun 25;527(2):425-431. doi: 10.1016/j.bbrc.2020.04.058. Epub 2020 Apr 22.
3
Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.
高度精确的慢性髓性白血病染色体平衡易位断点检测:病例系列。
J Cell Mol Med. 2022 Sep;26(17):4721-4726. doi: 10.1111/jcmm.17500. Epub 2022 Jul 28.
4
RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia.RHOA 调控的 IGFBP2 促进浸润并驱动 BCR-ABL1 慢性髓性白血病进展。
Haematologica. 2023 Jan 1;108(1):122-134. doi: 10.3324/haematol.2022.280757.
5
RAP1/TERF2IP-A Multifunctional Player in Cancer Development.RAP1/TERF2IP——癌症发展中的多功能参与者
Cancers (Basel). 2021 Nov 27;13(23):5970. doi: 10.3390/cancers13235970.
6
Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?慢性髓性白血病的遗传生物标志物:迄今为止我们了解到了什么?
Int J Mol Sci. 2021 Nov 19;22(22):12516. doi: 10.3390/ijms222212516.
Rap1 调节造血干细胞存活,并影响肿瘤发生和对化疗的反应。
Nat Commun. 2019 Dec 13;10(1):5349. doi: 10.1038/s41467-019-13082-9.
4
Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia.端粒缩短与慢性髓性白血病诊断时白血病干细胞负担相关。
Blood Adv. 2018 Jul 10;2(13):1572-1579. doi: 10.1182/bloodadvances.2018017772.
5
TERT Promoter Mutations but not the Alternative Lengthening of Telomeres Phenotype Are Present in a Subset of Ependymomas and Are Associated With Adult Onset and Progression to Ependymosarcoma.端粒酶逆转录酶(TERT)启动子突变而非端粒替代延长表型存在于一部分室管膜瘤中,且与成人发病及进展为室管膜肉瘤相关。
J Neuropathol Exp Neurol. 2017 Jan 1;76(1):61-66. doi: 10.1093/jnen/nlw106.
6
Diosmin-induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity.地奥司明诱导不同p53状态和ERK活性的乳腺癌细胞衰老、凋亡和自噬。
Toxicol Lett. 2017 Jan 4;265:117-130. doi: 10.1016/j.toxlet.2016.11.018. Epub 2016 Nov 24.
7
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.CNVkit:通过靶向DNA测序进行全基因组拷贝数检测与可视化
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873. doi: 10.1371/journal.pcbi.1004873. eCollection 2016 Apr.
8
Molecular basis of telomere dysfunction in human genetic diseases.人类遗传疾病中端粒功能障碍的分子基础。
Nat Struct Mol Biol. 2015 Nov;22(11):867-74. doi: 10.1038/nsmb.3093.
9
Complex interactions between the DNA-damage response and mammalian telomeres.DNA损伤反应与哺乳动物端粒之间的复杂相互作用。
Nat Struct Mol Biol. 2015 Nov;22(11):859-66. doi: 10.1038/nsmb.3092.
10
Control of telomerase action at human telomeres.人类端粒处端粒酶作用的调控。
Nat Struct Mol Biol. 2015 Nov;22(11):848-52. doi: 10.1038/nsmb.3083.